PM CET, Oxurion NV (Euronext Brussels: OXUR), an innovative biopharmaceutical company based in Leuven, today announces important progress in its preclinical program targeting Geographic Atrophy (GA), ...

Alphen aan den Rijn – May 6, 2024 – Wolters Kluwer, a global leader in professional information, software solutions, and services, today unveiled its dedicated AI center. The launch marks the company ...

Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.

Gen AI Text Summarization will first be introduced in Epiq Discovery , an application within the Epiq Service Cloud, and a leading cloud-based SaaS solution supporting full matter lifecycle ...

Exodus Movement, Inc. (OTCQX: EXOD) (“Exodus” or the “Company”), the leading self-custodial cryptocurrency software platform, today announced that its common stock has been approved for listing on the ...

Today marks a pivotal development for Brains Bioceutical Corp ("Brains Bio"), as it significantly strengthens its Veterinary Health Division. This enhancement is led by John Boshart, a distinguished ...

In honor of the 60th anniversary of Marimekko’s most beloved print Unikko, the Marimekko Day fashion show will also extend to Tokyo for the first time on 18 May. During the strategy period of ...

Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.

SATO Corporation, Press release 6 May 2024 at 9:00 am. In Leppävaara, Espoo, 100 rental apartments have just become available in SATO's unique building. The apartments are compac ...

In the U.S., Lantheus received approval for PYLARIFY® (Piflufolastat (18F) Injection) from the Food and Drug Administration (FDA) in May 2021. It is the #1 utilized PSMA PET agent in the U.S. market.

By enrolling in this course, participants will empower themselves with the expertise needed to navigate the complexities of Pillar Two. Visit the course webpage for more information ...

Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received approval from Health Canada for the marketing and commercial distribution of its NBS 6 system for the treatment of Major Depressive ...